Phenylephrine Hydrochloride Injection, USP 100 mg/10 mL (10 mg/mL), Rx Only, 10 mL Vial, Manufac...

FDA Recall #D-0403-2023 — Class II — February 7, 2023

Recall #D-0403-2023 Date: February 7, 2023 Classification: Class II Status: Terminated

Product Description

Phenylephrine Hydrochloride Injection, USP 100 mg/10 mL (10 mg/mL), Rx Only, 10 mL Vial, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, INDIA; NDC 16729-466-03, UPC 3 16729 46603 5

Reason for Recall

CGMP Deviations: recalling drug products following an FDA inspection.

Recalling Firm

Accord Healthcare, Inc. — Durham, NC

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

37,691 vials

Distribution

United States including Puerto Rico and Canada

Code Information

Batches: R2101591, R2101590, R2101599, Exp. Date 11/30/2023

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated